Mood Swings and Irritability in a Patient With Cystic Fibrosis on Elexacaftor-Tezacaftor-Ivacaftor Therapy A Case Report

被引：0
|
作者：
Lan, Yu-Tung [1 ]
Wung, Yu-Ting [2 ]
机构：
[1] Univ North Dakota, Dept Psychiat, Fargo, ND 58105 USA
[2] Sanford Hlth, Dept Psychiat, Fargo, ND USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2024年 / 44卷 / 05期
关键词：
D O I：
10.1097/JCP.0000000000001906
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：528 / 530
页数：3
相关论文
共 50 条
  • [41] Effects of elexacaftor-tezacaftor-ivacaftor on daily treatment burden and airflow obstruction in adults with cystic fibrosis
    Tiotiu, Angelica
    Ioan, Iulia
    Billon, Yves
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 82
  • [42] Worsening Anxiety With Elexacaftor-Tezacaftor-Ivacaftor: Navigating the Mental Health and Pulmonary Implications in an Adolescent Patient With Cystic Fibrosis
    Hughes, A.
    Brown, R. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [43] Changes in cystic fibrosis transmembrane conductance regulator protein expression prior to and during elexacaftor-tezacaftor-ivacaftor therapy
    Stanke, Frauke
    Pallenberg, Sophia T.
    Tamm, Stephanie
    Hedtfeld, Silke
    Eichhorn, Ella M.
    Minso, Rebecca
    Hansen, Gesine
    Welte, Tobias
    Sauer-Heilborn, Annette
    Ringshausen, Felix C.
    Junge, Sibylle
    Tuemmler, Burkhard
    Dittrich, Anna-Maria
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [44] CGM patterns in adults with cystic fibrosis-related diabetes before and after elexacaftor-tezacaftor-ivacaftor therapy
    Crow, Hanna
    Bengtson, Charles
    Shi, Xiaosong
    Graves III, Leland
    Anabtawi, Abeer
    JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY, 2022, 30
  • [45] Sodium intake of adults with cystic fibrosis living in north Queensland post elexacaftor-tezacaftor-ivacaftor
    Herd, Karen
    Matson, Angela
    Loel, Felicity
    Moore, Vanessa
    Evans, Ieuan
    RESPIROLOGY, 2024, 29 : 25 - 26
  • [46] A pediatric cystic fibrosis arthropathy case who responded to Elexacaftor/ Tezacaftor/Ivacaftor therapy
    Arslan, Meliksah
    Bahadir, Zeynep
    Basiaga, Matthew L.
    Chalmers, Sarah J.
    Demirel, Nadir
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 (06) : 1120 - 1122
  • [47] Case Report: A delicate equilibrium of exocrine pancreatic recovery and hepatotoxicity with elexacaftor/tezacaftor/ivacaftor therapy in a pediatric patient with cystic fibrosis
    Coughlin, Michael P.
    Sankararaman, Senthilkumar
    Roesch, Erica A.
    Certo, Emily D.
    Brej, Benjamin L.
    Konstan, Michael W.
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [48] Real world study on elexacaftor-tezacaftor-ivacaftor impact on cholesterol levels in adults with cystic fibrosis
    Lonabaugh, Kevin
    Li, Galvin
    List, Rhonda
    Huang, Reyna
    James, Amber
    Barros, Andrew
    Somerville, Lindsay
    Albon, Dana
    PHARMACOTHERAPY, 2024, 44 (03): : 231 - 240
  • [49] Tolerance of elexacaftor/tezacaftor/ivacaftor in Australians with cystic fibrosis
    Ruseckaite, Rasa
    Wark, Peter
    Pourghaderi, Ahmadreza
    Caruso, Marisa
    Ahern, Susannah
    RESPIROLOGY, 2024, 29 : 8 - 8
  • [50] Clinical change 2 years from start of elexacaftor-tezacaftor-ivacaftor in severe cystic fibrosis
    McCoy, Karen S.
    Blind, Jill
    Johnson, Terri
    Olson, Patti
    Raterman, Laura
    Bai, Shasha
    Eisner, Mariah
    Sheikh, Shahid I.
    Druhan, Stephan
    Young, Cody
    Pasley, Kimberly
    PEDIATRIC PULMONOLOGY, 2023, 58 (04) : 1178 - 1184
12345